Conditions: Major Depressive Disorder
Keywords: Major Depressive Disorder MDD Depression
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 283
Healthy volunteers: no

Brief summary:
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Child and Adolescent Outpatients with Major Depressive Disorder (MDD).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: DVS SR
Intervention descriptions: intervention 1: Subjects will receive a flexible-dose of 20, 25, 35, or 50 mg/day as prescribed by the investigator

Protocol document: